Myeloid sarcoma: more and less than a distinct entity

GG Loscocco, AM Vannucchi - Annals of Hematology, 2023 - Springer
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour
mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most …

Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential …

M Zanelli, F Sanguedolce, M Zizzo, V Fragliasso… - Cancers, 2023 - mdpi.com
Simple Summary Pathologists working with skin biopsies of different hematological
malignancies via blastic morphology need to consider a broad spectrum of diseases that …

Contribution of Nucleotide-Binding Oligomerization Domain-like (NOD) Receptors to the Immune and Metabolic Health

CJ Apaza, M Días, A García Tejedor, L Boscá… - Biomedicines, 2024 - mdpi.com
Nucleotide-binding oligomerization domain-like (NOD) receptors rely on the interface
between immunity and metabolism. Dietary factors constitute critical players in the activation …

Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm

M Piccini, GG Loscocco, G Gianfaldoni, P Grieco… - Annals of …, 2020 - Springer
Dear Editor, Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and extremely
aggressive myeloid malignancy arising from dendritic cell (DC) precursors typically affecting …